{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:47:52Z","timestamp":1781768872851,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008091","name":"Golestan University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["112883"],"award-info":[{"award-number":["112883"]}],"id":[{"id":"10.13039\/501100008091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.diagmicrobio.2024.116606","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T16:19:46Z","timestamp":1731773986000},"page":"116606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-biofilm activity of carvacrol-thymoquinone nanocarriers on vulvovaginal candidiasis isolates"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6053-1186","authenticated-orcid":false,"given":"Maryam","family":"Hajiaghaalizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Sheikharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Saghaeian","family":"Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheleh","family":"Alhashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Sedigheh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116606_bib0001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3949\/ccjm.84a.15163","article-title":"Vulvovaginitis: find the cause to treat it","volume":"84","author":"Goje","year":"2017","journal-title":"Clevel Clin J Med"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116606_bib0002","first-page":"836","article-title":"Mutation in hotspot regions of the Erg11 gene and fluconazole resistance In clinical isolates of Candida Albicans in Rasht City","volume":"30","author":"Balabandi","year":"2019","journal-title":"Stud Med Sci"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116606_bib0003","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/ijstd.IJSTD_49_18","article-title":"Clinicomycological study of vulvovaginal candidiasis","volume":"42","author":"Seeniammal","year":"2021","journal-title":"Indian J Sex Transm Dis AIDS"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116606_bib0004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/14787210.2024.2347953","article-title":"Treatment of vaginitis caused by non-albicans Candida species","volume":"22","author":"Sobel","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116606_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2020.100966","article-title":"Candida africana vulvovaginitis: prevalence and geographical distribution","volume":"30","author":"Fakhim","year":"2020","journal-title":"J Mycol Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116606_bib0006","doi-asserted-by":"crossref","first-page":"44","DOI":"10.18869\/acadpub.pbr.2.1.44","article-title":"Encapsulation of nystatin in nanoliposomal formulation: characterization, stability study and antifungal activity against Candida albicans","volume":"2","author":"Saadat","year":"2016","journal-title":"Pharm Biomed Res"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116606_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-018-1316-3","article-title":"Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.diagmicrobio.2024.116606_bib0008","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2147\/IJN.S241134","article-title":"Ultrasound-assisted preparation of exopolysaccharide\/nystatin nanoemulsion for treatment of vulvovaginal candidiasis","author":"Song","year":"2020","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116606_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.riam.2022.01.004","article-title":"In vitro activity of juglone (5-hydroxy-1,4-naphthoquinone) against both fluconazole-resistant and susceptible Candida isolates","volume":"39","author":"Vaezi","year":"2022","journal-title":"Rev Iberoam Micol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116606_bib0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/pharmaceutics13050678","article-title":"Lipid-based nanocarriers as topical drug delivery systems for intraocular diseases","volume":"13","author":"Navarro-Partida","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116606_bib0011","first-page":"31","article-title":"Niosome-loaded antifungal drugs as an effective nanocarrier system: a mini review","volume":"4","author":"Osanloo","year":"2018","journal-title":"Curr Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2024.116606_bib0012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fcimb.2020.00192","article-title":"Carvacrol induces Candida albicans apoptosis associated with Ca2+\/calcineurin pathway","volume":"10","author":"Niu","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116606_bib0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.52547\/iem.8.2.169","article-title":"Design and synthesis of novel thymoquinone-zein nanoparticles; evaluation of the inhibitory effect on Candida albicans and biofilm formation in vitro","volume":"8","author":"Rahsepar","year":"2022","journal-title":"Infect Epidemiol Microbiol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2024.116606_bib0014","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1111\/jog.15442","article-title":"Vulvovaginal candidiasis in Iranian women: molecular identification and antifungal susceptibility pattern","volume":"48","author":"Khaksar Baniasadi","year":"2022","journal-title":"J Obstet Gynaecol Res"},{"issue":"1S","key":"10.1016\/j.diagmicrobio.2024.116606_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21010\/ajid.v12i1S.13","article-title":"Risk factors of vulvovaginal candidiasis in dermato-venereology outpatients clinic of soetomo general hospital, Surabaya, Indonesia","volume":"12","author":"Arfiputri","year":"2018","journal-title":"Afr J Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116606_bib0016","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.xphs.2016.02.018","article-title":"Methocel-lipid hybrid nanocarrier for efficient oral insulin delivery","volume":"105","author":"Boushra","year":"2016","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116606_bib0017","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1099\/jmm.0.000426","article-title":"Utilization of size polymorphism in ITS1 and ITS2 regions for identification of pathogenic yeast species","volume":"66","author":"Khodadadi","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2024.116606_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102166","article-title":"Morphology and microstructural analysis of bioactive-loaded micro\/nanocarriers via microscopy techniques; CLSM\/SEM\/TEM\/AFM","volume":"280","author":"Falsafi","year":"2020","journal-title":"Adv Colloid Interface Sci"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116606_bib0019","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/08982104.2019.1600545","article-title":"Enhanced nuclear translocation and activation of aryl hydrocarbon receptor (AhR) in THP-1 monocytic cell line by a novel niosomal formulation of indole-3-carbinol","volume":"30","author":"Abbaspour Sani","year":"2020","journal-title":"J Liposome Res"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116606_bib0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/jac\/dkz568","article-title":"MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method","volume":"75","author":"Borman","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2024.116606_bib0021","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/microorganisms10102091","article-title":"Vaginal Lactobacillus impair Candida dimorphic switching and biofilm formation","volume":"10","author":"Parolin","year":"2022","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116606_bib0022","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3906\/sag-1909-97","article-title":"Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3reference method to determine the activity of antifungal agents against clinical isolatesof Candida spp","volume":"50","author":"Altinba\u015f","year":"2020","journal-title":"Turk J Med Sci"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116606_bib0023","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1128\/JCM.00654-09","volume":"47","author":"Espinel-Ingroff","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2024.116606_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112334","article-title":"Discovery of novel thiosemicarbazides containing 1,3,5-triazines derivatives as potential synergists against fluconazole-resistant Candida albicans","volume":"14","author":"Xie","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116606_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mycmed.2018.02.007","article-title":"Evaluation of biofilm formation ability in different Candida strains and anti-biofilm effects of Fe(3)O(4)-NPs compared with Fluconazole: an in vitro study","volume":"28","author":"Salari","year":"2018","journal-title":"J Mycol Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116606_bib0026","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/1040841X.2020.1843400","article-title":"Candida albicans biofilms and polymicrobial interactions","volume":"47","author":"Ponde","year":"2021","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.diagmicrobio.2024.116606_bib0027","doi-asserted-by":"crossref","DOI":"10.4155\/tde-2023-0090","article-title":"Nanotherapeutics for the delivery of antifungal drugs","author":"Aderibigbe","year":"2024","journal-title":"Ther Deliv"},{"key":"10.1016\/j.diagmicrobio.2024.116606_bib0028","first-page":"1","article-title":"Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study","author":"Zincir","year":"2022","journal-title":"Odontology"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116606_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13040580","article-title":"Thymoquinone antifungal activity against Candida glabrata oral isolates from patients in Intensive care units-an in vitro study","volume":"13","author":"Nouri","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116606_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ph17010089","article-title":"Biochanin A inhibits the growth and biofilm of Candida species","volume":"17","author":"Janeczko","year":"2024","journal-title":"Pharmaceuticals"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324004309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324004309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T20:34:20Z","timestamp":1733517260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324004309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0732889324004309"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116606","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-biofilm activity of carvacrol-thymoquinone nanocarriers on vulvovaginal candidiasis isolates","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116606"}}